Effects of Side-Effect Risk Framing Strategies on COVID-19 Vaccine Intentions in the United States and the United Kingdom: A Randomized Controlled Trial

Nikkil Sudharsanan, Caterina Favaretti, Violetta Hachaturyan, Till Bärnighausen, Alain Vandormael
doi: https://doi.org/10.1101/2021.10.12.21264877

Article Information

doi 
https://doi.org/10.1101/2021.10.12.21264877
History 
  • October 14, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Nikkil Sudharsanan1,2,*,
  2. Caterina Favaretti2,
  3. Violetta Hachaturyan2,
  4. Till Bärnighausen2,3 and
  5. Alain Vandormael2
  1. 1Technical University of Munich
  2. 2Heidelberg Institute of Global Health
  3. 3Harvard T.H. Chan School of Public Health
  1. ↵*Corresponding author; email: nikkil.sudharsanan{at}tum.de
Back to top
Posted October 14, 2021.
Download PDF
Data/Code
Email
Effects of Side-Effect Risk Framing Strategies on COVID-19 Vaccine Intentions in the United States and the United Kingdom: A Randomized Controlled Trial
Nikkil Sudharsanan, Caterina Favaretti, Violetta Hachaturyan, Till Bärnighausen, Alain Vandormael
medRxiv 2021.10.12.21264877; doi: https://doi.org/10.1101/2021.10.12.21264877
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area